Recruiting Obesity Studies in Gulfport
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
The purpose of this pediatric, chronic weight management, Phase 3 Master Protocol (PWMP) is to create a framework to evaluate the safety and efficacy of pharmacologic agents for the treatment of obesi...
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
The main purpose of this study, performed under Master Protocol J4M-MC-PWMP, is to evaluate the efficacy, safety, and pharmacokinetics of orforglipron once daily oral versus Placebo in adolescent part...
About Obesity Clinical Trials in Gulfport
Obesity is a complex chronic disease involving an excessive amount of body fat that increases the risk of other diseases and health problems. It affects over 650 million adults worldwide. Treatment approaches include lifestyle modifications, medications (GLP-1 agonists), and bariatric surgery.
There are currently 2 obesity clinical trials recruiting participants in Gulfport, MS. These studies are seeking a combined 250 participants. Research is being sponsored by Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Obesity Clinical Trials in Gulfport — FAQ
Are there obesity clinical trials in Gulfport?
Yes, there are 2 obesity clinical trials currently recruiting in Gulfport, MS. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Gulfport?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gulfport research site will contact you about next steps.
Are clinical trials in Gulfport free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gulfport studies also compensate for your time and travel.
What obesity treatments are being tested?
The 2 active trials in Gulfport are testing new therapies including novel drugs, biologics, and treatment approaches for obesity.
Data updated March 2, 2026 from ClinicalTrials.gov